IBXXF fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. It offers MagSense technology which does not use ionizing radiation, radioactive tracers, or strong magnetic fields; and PrecisionMRX nanoparticles, which is used for magnetic relaxometry and other biomedical applications where the magnet susceptibility of the nanoparticle can be instrumental. The company was founded by Edward R. Flynn on December 6, 2016 and is headquartered in Melbourne, Australia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
IBXXF does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company